FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors

LUMAXIND

1,280
-17.6 (-1.36%)
Updated 03:25 10/07 IST

LUMAXIND Buy or Sell - FrontPage Forums

0 Users have submitted 0 trade ideas of Rs. 0 for LUMAXIND
Disclaimer
0% Bullish
0% Bearish

LUMAXIND Buy or Sell - Brokerage Reports

No. of reports in last year
7
No. of analysts
4
Average Consensus Forecast
1533.57
Consensus Potential
10.91%
See LUMAXIND Share Price Targets >>

LUMAXIND Ratings

Long term LUMAXIND rating by FrontPage users
4.8/5 (5 Ratings)
Find answers to all your questions on live LUMAXIND message board: Is LUMAXIND buy or sell? Should I buy LUMAXIND shares? Why are LUMAXIND shares falling? Should I invest in LUMAXIND stock?

  1. Home
  2. LUMAXIND Forum

LUMAXIND Share Price Discussion

N
Reputation: 3,465 • Jun 19 3:03 AM
Lumax Inds Standalone March 2020 Net Sales at Rs 387.29 crore, down 10.49% Y-o-Y
Moneycontrol
Like
Reply
K
Reputation: 15,422 • Jun 18 2:35 AM

LUMAX INDUSTRIES: RECOMMENDED FINAL DIVIDEND OF 6 RUPEES/SHARE
Like
Reply
D
Reputation: 14,257 • May 8 4:00 AM

Axis Direct target on LUMAXIND
Date: 05-May-20 Broker: Axis Direct Price @ Call: 982.81 Target: 886 Recommendation: SELL
Like
Reply
N
Reputation: 3,465 • Feb 24 3:43 AM
Lumax Industries Q3 – In-line numbers, a proxy play on LEDs
Moneycontrol
Like
Reply
D
Reputation: 14,257 • Feb 13 9:00 AM

Axis Direct target on LUMAXIND
Date: 13-Feb-20 Broker: Axis Direct Price @ Call: 1515 Target: 1915 Recommendation: BUY
Like
Reply
N
Reputation: 3,465 • Feb 5 1:38 AM
Stocks in the news: Bharti Airtel, Adani Ent, Cadila, Sun Pharma, Reliance Power, Bharat Wire Ropes
Bharti Airtel | Adani Ent | Cadila | Sun Pharma | Reliance Power | Bharat Wire Ropes and Tata Global Beverages are among the companies that are in the news today.
Moneycontrol
Like
Reply
D
Reputation: 14,257 • Dec 31, 2019 11:00 AM

CD Equisearch target on LUMAXIND
Date: 31-Dec-19 Broker: CD Equisearch Price @ Call: 1300 Target: 1558 Recommendation: ACCUMULATE
Like
Reply
T
Reputation: -842 • Dec 26, 2019 2:26 AM

LUMAXIND - chart - 498885
(TMT) LUMAX IND. LTD. (1279.40):- STOCK TRADING IN THE RANGE LAST MANY DAYS TODAY PRICE MOVE WITH HEAVY VOLUME ALSO CLOSE ABOVE OUR MAGICAL TREND AVERAGE...ENTER AT CMP AND ADD MORE ABOVE 1330 TGT 1550+ SUPPORT ZONE 1220
Like
Reply (1)
Latest replies
TMT VIEW @tmtview
Jan 11 7:26 AM

1410+
D
Reputation: 14,257 • Nov 25, 2019 9:00 AM

Edelweiss target on LUMAXIND
Date: 25-Nov-19 Broker: Edelweiss Price @ Call: 1235 Target: 1500 Recommendation: BUY
Like
Reply
N
Reputation: 3,465 • Oct 18, 2019 3:43 AM
Global, local cues backing bulls; time ripe to bet on these 20 picks for up to 41% return by next Diwali
Dinesh Thakkar of Angel Broking said though MF inflows this year have slowed down, he was very confident that MF inflows will pick up from here on as market sentiments improve.
Moneycontrol
Like
Reply
D
Reputation: 14,257 • Oct 12, 2019 5:00 AM

Axis Direct Recommendation on LUMAXIND
Date: 10-Oct-19 Broker: Axis Direct Price @ Call: 1129.42 Target: 1600 Recommendation: BUY
Like
Reply
N
Reputation: 3,465 • Aug 10, 2019 3:28 AM
Govt pep talk helps market snap 4-week losing streak; 19 stocks rose 10-30% in BSE500
Such sharp rallies are often a result of some pep talk or some relief measure which often fizzles out trapping the bulls who bought on the hopes that a new rally will begin.
www.moneycontrol.com
Like
Reply
N
Reputation: 3,465 • Aug 2, 2019 10:13 AM
Lumax Inds Standalone June 2019 Net Sales at Rs 402.02 crore, down 18.98% Y-o-Y
moneycontrol.com
Like
Reply
N
Reputation: 3,465 • May 23, 2019 4:48 AM
Like
Reply
N
Reputation: 3,465 • Apr 8, 2019 1:23 AM
Like
Reply
N
Reputation: 3,465 • Feb 18, 2019 1:17 AM
Like
Reply
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 50,000 Indian traders and discuss trades, strategies, news & views on any stock.
  • LUMAXIND - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization1,636.83
    Enterprise Value1,772.59
    Price to Earnings32.22
    Price to Book Value4.4
    Return on Capital Employed0.24
    Return on Equity0.22
    Face Value10
    Dividend Yield0.01
  • LUMAXIND - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    5-May-20Axis DirectSell886
    13-Feb-20Axis DirectBuy1,915
    31-Dec-19CD EquisearchAccumulate1,558
    25-Nov-19EdelweissBuy1,500
    10-Oct-19Axis DirectBuy1,600
    LUMAXIND Brokerage Price Target
  • LUMAXIND Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Jul 101296.11298.351272.051283.75
    Jul 81259.95131012511258.65
    Jul 71210.0512801210.051259.4
    Jul 61260129812251233.25
    Jul 3119012901175.11259.8
  • LUMAXIND Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹1,113.3
    30 Day Moving Average₹1,061.01
    50 Day Moving Average₹1,016.26
    100 Day Moving Average₹1,080.78
    200 Day Moving Average₹1,180.66
  • LUMAXIND - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue1,691.771,299.780.3
    Operating Profit135.199.810.35
    Profit Before Tax87.9254.160.62
    Net Income63.2445.180.4
  • LUMAXIND - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds372292.870.27
    Total Liabilities742917.81-0.19
    Total Assets1,1141,210.68-0.08
  • LUMAXIND - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity140.1100.080.4
    Cash from Investing Activity-128.36-62.081.07
    Cash from Financing Activity-11.17-40.24-0.72
    Net Cash Flow0.57-2.24-1.25
  • LUMAXIND - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.050.05
    Return on Equity0.220.19
    Return on Capital Employed0.240.2
  • LUMAXIND - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.48
    3 Year CAGR Growth in Operating Profit1.28
    3 Year CAGR Growth in EBIDTA1.23
    3 Year CAGR Growth in Net Income2.82
    3 Yr CAGR Growth - Diluted EPS2.82
  • LUMAXIND - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue0.58
    5 Year CAGR Growth in Operating Profit1.21
    5 Year CAGR Growth in EBIDTA1.19
    5 Year CAGR Growth in Net Income3.65
    3 Yr CAGR Growth - Diluted EPS3.65
  • LUMAXIND - Recent News

    keyboard_arrow_down
    NewsBot
    Jun 19 3:03 AM
    Lumax Inds Standalone March 2020 Net Sales at Rs 387.29 crore, down 10.49% Y-o-Y
    Moneycontrol
    NewsBot
    Feb 24 3:43 AM
    Lumax Industries Q3 – In-line numbers, a proxy play on LEDs
    Moneycontrol
    NewsBot
    Feb 5 1:38 AM
    Stocks in the news: Bharti Airtel, Adani Ent, Cadila, Sun Pharma, Reliance Power, Bharat Wire Ropes
    Moneycontrol
    NewsBot
    Oct 18, 2019 3:43 AM
    Global, local cues backing bulls; time ripe to bet on these 20 picks for up to 41% return by next Diwali
    Moneycontrol
    NewsBot
    Aug 10, 2019 3:28 AM
    Govt pep talk helps market snap 4-week losing streak; 19 stocks rose 10-30% in BSE500
    www.moneycontrol.com
    NewsBot
    Aug 2, 2019 10:13 AM
    Lumax Inds Standalone June 2019 Net Sales at Rs 402.02 crore, down 18.98% Y-o-Y
    moneycontrol.com
    NewsBot
    May 23, 2019 4:48 AM
    NewsBot
    Apr 8, 2019 1:23 AM
    NewsBot
    Apr 7, 2019 12:43 PM
    NewsBot
    Mar 8, 2019 5:47 AM
  • LUMAXIND - Related Communities

    keyboard_arrow_down
    Motherson Sumi Systems Ltd. NSE: MOTH...
    Amara Raja Batteries Ltd. NSE: AMARAJ...
    Exide Industries Ltd. NSE: EXIDEIND |...
    Rane Brake Lining Ltd. NSE: RBL | BSE...
    Jamna Auto Industries Ltd. NSE: JAMNA...
    Bosch Ltd. NSE: BOSCHLTD | BSE: 50053...
    Minda Industries Ltd. NSE: MINDAIND |...
    Minda Corporation Ltd. NSE: MINDACORP...
    Endurance Technologies Ltd. NSE: ENDU...
    Rico Auto Industries Ltd. NSE: RICOAU...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.

PrivacyTerms
FrontPage © 2020